Evidence map›Paper›PMID 40854648›Full record

ArticleJournal, genetic engineering & biotechnology2025

Integrative bioinformatics and deep learning to identify common genetic pathways in Crohn's disease and ischemic cardiomyopathy.

Reza Maddah, Zahra Sadat Aghili, Fahimeh Ghanbari, Amirhossein Hajialiasgary Najafabadi, Sedigheh Asgary

Abstract read
In one paragraph

Article in Journal, genetic engineering & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Reza MaddahDepartment of Bioprocess Engineering, Institute of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
Zahra Sadat AghiliDepartment of Molecular Medicine, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Fahimeh GhanbariApplied Physiology Research Center, Isfahan University of Medical Sciences, Iran.
Amirhossein Hajialiasgary NajafabadiDepartment of Quantitative and Computational Biology, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany; Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran.
Sedigheh AsgaryDepartment of Pharmaceutical Sciences, Cardiovascular Research Institute, Isfahan University of Medical Science, Iran. Electronic address: sedighehasgary@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crohn's disease (CD) and ischemic cardiomyopathy (ICM) share inflammatory characteristics, yet their common genetic underpinnings remain underexplored. Using an integrative bioinformatics approach, we analyzed GEO datasets (GSE3365 and GSE9128) to identify shared genetic pathways between CD and ICM. Through differential expression analysis, we identified 60 common differentially expressed genes (CDEGs). Functional enrichment analysis revealed enrichment in inflammatory pathways, including NF-κB and TNF-α signaling, highlighting their role in disease pathogenesis. We conducted microRNA (miRNA), transcription factor (TF), and protein-protein interaction (PPI) analyses to uncover regulatory networks. Notably, hsa-miR-98-5p emerged as a key miRNA, while RELA and NFKB1 were identified as prominent TFs interacting with CDEGs. Six hub genes-IL1B, CXCL8, CXCL2, TLR2, FCGR1A, and FCGR2A-were pinpointed, demonstrating high diagnostic potential via receiver operating characteristic (ROC) analysis. To advance diagnostic precision, we developed AutoClass, a deep learning framework that leverages hub gene regulatory networks to classify CD patients with approximately 95 % accuracy. These hub genes and regulators likely drive neutrophil-mediated inflammation, offering insights into the molecular interplay between CD and ICM. Our findings suggest that the identified CDEGs, miRNAs, and TFs hold promise as therapeutic targets and biomarkers, paving the way for precision medicine approaches in managing CD and its cardiovascular complications. Future experimental validation and cohort expansion could further elucidate these shared mechanisms, enhancing their translational impact.

Indexed as

AutoClass, bioinformaticsCrohn’s diseaseDeep learningGenetic pathwaysHub genesInflammatory mechanismsIschemic cardiomyopathy

Identifiers

PMID40854648
PMCPMC12268078

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.